Nils Gustav Thomas Bengtsson

Title: Innovations by Nils Gustav Thomas Bengtsson

Introduction

Nils Gustav Thomas Bengtsson is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of medical imaging and treatment prediction, holding a total of three patents. His work focuses on utilizing advanced neural networks to enhance the accuracy and effectiveness of medical treatments.

Latest Patents

One of his latest patents is titled "Deep neural network framework for processing OCT images to predict treatment intensity." This invention relates to processing optical coherence tomography (OCT) images to predict the characteristics of treatments for age-related macular degeneration. The method includes pre-processing the images and employing a deep convolutional neural network to predict treatment frequency and intervals, thereby preventing vascular leakage in the eye.

Another notable patent is "Automated tumor identification and segmentation with medical images." This patent describes a system where medical images are input into a detection network to identify regions that may contain tumors. The system generates segmentation boundaries for the tumors and determines the organs in which they are located, enhancing the precision of tumor detection and treatment planning.

Career Highlights

Nils Bengtsson is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to apply his expertise in neural networks to real-world medical challenges, contributing to advancements in patient care.

Collaborations

Throughout his career, Nils has collaborated with notable colleagues, including Richard Alan Duray Carano and Jill Fredrickson. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Nils Gustav Thomas Bengtsson is a prominent inventor whose work in medical imaging and treatment prediction has the potential to transform patient care. His innovative patents and contributions to Genentech, Inc. highlight his commitment to advancing medical technology.